Critique of extracorporeal photopheresis for treatment of cutaneous T-cell lymphoma (2016)

Critique of extracorporeal photopheresis for treatment of cutaneous T-cell lymphoma (2016)

The Department of Health engaged HealthConsult to undertake a critique of a protocol provided to the Medical Services Advisory Committee (MSAC) to include extracorporeal photopheresis on the Medicare Benefits Schedule (MBS) for patients with cutaneous T-cell lymphoma. The critique will be considered by the Protocol Advisory Sub-Committee (PASC). The project commenced in April 2016 and was completed in May 2016.